InvestorsHub Logo
Followers 13
Posts 1239
Boards Moderated 0
Alias Born 05/04/2010

Re: None

Thursday, 07/17/2014 9:38:25 AM

Thursday, July 17, 2014 9:38:25 AM

Post# of 84944

Herborium Group's Second Quarter Sales Grows over 132%
The Company anticipates exceeding a million dollars in sales in 2014
GlobeNewswire
Herborium Group, Inc. 1 hour ago

Fort Lee, New Jersey, July 17, 2014 (GLOBE NEWSWIRE) -- Fort Lee, N.J. July 16, 2014 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, reports that its sales for the Second Quarter of 2014 grew by 132 % in comparison to the same period of 2013. This puts the present run rate for AcnEase(R) sales for 2014 to exceed $1 million dollars. .

During the first six months (ending 5/31/2014) of 2014, Herborium's sales increased 86% in comparison to the same six month period in 2013. The Company's Gross Profit increased 2.5 fold and the loss from operations for the same period decreased 86%. The Company continues its expansion of AcnEase(R) in French market and has also began penetrating Spanish and Spanish speaking markets with a newly established Spanish Website and related e-commerce strategy. The Company's Facebook following is approaching 10,000 people.

Herborium remains very optimistic about growing its business, sales and product awareness due to the steady growth of the AcnEase(R) brand as well as its three new products that have already generated interest and will enter the market this year. The Company continues its efforts to decrease costs. While still recognizing the expenses associated with developing and launching new products and the associated upfront costs. Herborium continues to retire debt, thus increasing the Company's ability to raise outside funds at a reasonable cost. There is a rising interest in Botanical Therapeutics(R) among consumers as well as both the financial and medical communities that can serve as a solid foundation for the company's promising future.

These developments put the Company closer to executing the up listing plan announced in 2013.